Three Cases of Diffuse, Intense Stomach Uptake on DOTATATE PET.

Incidental tracer uptake on DOTATATE PET is increasingly encountered in clinical practice. We describe 3 patients with suspected or known neuroendocrine tumor who were found to have diffuse and intense stomach uptake on DOTATATE PET. All patients underwent esophagogastroduodenoscopy and/or endoscopic ultrasound; the cause of the stomach uptake was attributed to proton-pump inhibitor use, chronic gastritis, and gastrinoma, respectively. These 3 cases highlight that diffuse and intense stomach DOTATATE uptake can be a benign finding probably attributed to proton-pump inhibitor use, chronic gastritis, or gastrinoma.

Citation

Martin S Auerbach, Joseph R Pisegna, Stephen Kim, Run Yu. Three Cases of Diffuse, Intense Stomach Uptake on DOTATATE PET. Clinical nuclear medicine. 2020 Oct;45(10):813-816

Mesh Tags

Substances

PMID: 32604111

search → result